Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
China Risun Group Limited (1907.HK)
Beijing, CN
China Risun Group Limited, founded in 1995 and headquartered in Beijing, People's Republic of China, is a diversified enterprise focused on the manufacturing, sale, and distribution of coke, coking chemicals, and refined chemicals throughout the PRC and via export. The company structures its operations across four primary divisions: Coke and Coking Chemicals Manufacturing, Refined Chemicals Manufacturing, Operation Management, and Trading. Its extensive portfolio of chemical products features items like crude benzene, industrial naphthalene phthalic anhydride, coke oven gas methanol, coal-tar pitch, and caprolactam. In addition to its production activities, China Risun provides operation management services to external coke and chemical firms, alongside offering training programs for safety management and operational proficiency. The group also actively trades in coke, coking chemicals, and refined chemical products, and is involved in real estate development initiatives. Its clientele spans critical sectors including iron and steel, non-ferrous metals, coking, and general chemical industries. The company was previously named China Risun Coal Chemicals Group Limited, changing to its current designation in July 2018.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.18% | -4.18% | -17.38% | -0.40% | +13.51% | +11.50% | +1.61% | -26.53% | -57.79% | -10.00% | -10.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-17.4% Q4'25: -25.7% (vs Q4'23)
-
EPS growth Chemicals: +11.7%+184.8% ★ Q4'25: -79.6% (vs Q4'23)
-
FCF margin FCF growth · Chemicals: +41.7%+0.3% Q4'25: -1.5% (vs Q4'23)
-
EBIT margin Chemicals: +7.1%+2.8% Q4'25: +1.9% (vs Q4'23)
-
ROIC Chemicals: +3.4%+1.7% Q4'25: +3.1% (vs Q4'23)
-
Share dilution Chemicals: +0.0%-1.3% ★ Q4'25: -3.2% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×12.02× Q4'25: 6.78× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
18.84B
est: 23.24B (-18.9%)
|
19.78B
est: 22.57B (-12.3%)
|
39.37B
est: 42.66B (-7.7%)
|
43.14B
est: 53.77B (-19.8%)
|
46.07B
est: 46.92B (-1.8%)
|
47.54B
est: 46.98B (+1.2%)
|
39.29B
est: 43.54B (-9.8%)
|
48.73B
48.37B – 49.10B
+11.9% YoY
|
50.56B
49.21B – 51.68B
+3.8% YoY
|
52.76B
51.84B – 53.55B
+4.3% YoY
|
| EBITDA |
2.19B
est: 2.68B (-18.2%)
|
3.22B
est: 1.95B (+64.9%)
|
5.45B
est: 2.16B (+152.4%)
|
4.63B
est: 2.55B (+81.7%)
|
4.37B
est: 4.63B (-5.6%)
|
3.50B
est: 4.63B (-24.4%)
|
3.09B
est: 4.29B (-27.9%)
|
4.80B
4.77B – 4.84B
+11.9% YoY
|
4.99B
4.85B – 5.10B
+3.8% YoY
|
5.20B
5.11B – 5.28B
+4.3% YoY
|
| EBIT |
1.54B
est: 1.74B (-11.6%)
|
2.48B
est: 1.38B (+79.3%)
|
4.10B
est: 1.53B (+167.9%)
|
3.20B
est: 1.80B (+77.4%)
|
2.03B
est: 2.60B (-21.9%)
|
1.28B
est: 2.60B (-50.9%)
|
1.09B
est: 2.41B (-55.0%)
|
2.70B
2.68B – 2.72B
+11.9% YoY
|
2.80B
2.73B – 2.86B
+3.8% YoY
|
2.92B
2.87B – 2.97B
+4.3% YoY
|
| Net Income |
1.37B
est: 1.54B (-10.8%)
|
1.65B
est: 1.12B (+47.1%)
|
2.61B
est: 1.24B (+110.2%)
|
1.86B
est: 833.81M (+122.5%)
|
860.81M
est: 233.04M (+269.4%)
|
20.13M
est: 258.06M (-92.2%)
|
58.01M
est: 86.01M (-32.6%)
|
1.20B
1.03B – 1.54B
+1,291.5% YoY
|
1.03B
202.55M – 2.06B
-13.7% YoY
|
1.49B
1.31B – 1.67B
+44.4% YoY
|
| SGA |
1.18B
est: 1.21B (-2.5%)
|
1.23B
est: 951.78M (+29.3%)
|
1.92B
est: 1.05B (+82.0%)
|
1.92B
est: 1.24B (+54.7%)
|
2.25B
est: 2.47B (-8.9%)
|
2.63B
est: 2.47B (+6.6%)
|
2.58B
est: 2.29B (+12.6%)
|
2.56B
2.54B – 2.58B
+11.9% YoY
|
2.66B
2.59B – 2.72B
+3.8% YoY
|
2.77B
2.73B – 2.82B
+4.3% YoY
|
| EPS |
0.35
est: 0.35 (-0.8%)
|
0.40
est: 0.38 (+4.2%)
|
0.61
est: 0.79 (-22.6%)
|
0.42
est: 0.40 (+5.6%)
|
0.19
est: 0.05 (+250.8%)
|
0.00
est: 0.06 (-92.3%)
|
0.01
est: 0.02 (-35.0%)
|
0.30
0.24 – 0.36
+1,388.3% YoY
|
0.33
0.05 – 0.48
+10.5% YoY
|
0.35
0.30 – 0.39
+5.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-28 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-27 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-26 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-22 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-21 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-20 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-19 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-18 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-15 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-14 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI China Small-Cap ETF ECNS | 0.17% | 111.3K | 0.59% |
| 2 | First Trust Emerging Markets Small Cap AlphaDEX Fund FEMS | 0.09% | 240.5K | 0.80% |
| 3 | FlexShares Morningstar Emerging Markets Factor Tilt Index Fund TLTE | 0.03% | 96.7K | 0.58% |
| 4 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.03% | 183.5K | 0.65% |
| 5 | iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L | 0.02% | 15.4K | 0.74% |
| 6 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.02% | 125.3K | 0.55% |
| 7 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.02% | 23.5K | 0.42% |
| 8 | iShares MSCI Emerging Markets Small-Cap ETF EEMS | 0.02% | 56.9K | 0.72% |
| 9 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.01% | 51.3K | 0.74% |
| 10 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 1.31M | 0.06% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Xuegang Yang | Chief Executive Officer & Chairman | 7M | male |
| Xiaomei Lu | Executive Director | 3M | female |
| Lu Yang | Vice President & Executive Director | 1M | male |
| Qinliang Han | Senior Vice President & Executive Director | 924.5K | male |
| Nianping Wang | Senior Vice President & Executive Director | 924.5K | male |
| Qinghua Li | Executive President & Executive Director | 924.5K | male |
| Yingwei Zhang | Senior Vice President | 249.6K | male |
| Pui Lam FCPA | Chief Financial Officer & Company Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1907.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
